窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 24 2026

Full Issue

FDA Unveils Framework To Fast-Track Rare Disease Gene Therapy Approvals

The proposed system would create a standardized process for authorizing cutting-edge treatments where there is a plausible reason to think they might work, the AP reported.

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the pharmaceutical industry has long considered unprofitable. The preliminary Food and Drug Administration guidelines, if implemented, would create a new pathway for bespoke therapies that have only been tested in a handful of patients due to the challenges of conducting larger studies. The FDA announcement specifically mentions gene editing, although agency officials said the new approach could also be used by other drugs and therapies. (Perrone, 2/23)

More news from the Trump administration

The federal prison system will stop providing gender-affirming medical or social transition care to almost any transgender people, undera new policy released by the Bureau of Prisons Thursday. (Schwartzapfel, 2/23)

The American Hospital Association is calling on federal health officials to reduce regulatory barriers and ensure clinician oversight as artificial intelligence becomes more integrated into clinical care. In a Feb. 23 letter to the Department of Health and Human Services, the AHA outlined recommendations in response to the agencys request for information on accelerating AI adoption in healthcare. (Diaz, 2/23)

This year, a substantial number of Democrats are planning to boycott the speech and attend an alternative event, a rally called the Peoples State of the Union, which will take place on the National Mall near the Capitol. Representative Hakeem Jeffries, Democrat of New York and the minority leader, has encouraged members to either sit silently through the speech or boycott it altogether, rather than attend and create distractions in the House chamber. Such protests potentially risk alienating swing voters ahead of the midterms. (Broadwater, 2/24)

In news about the Epstein files

Dr. Peter Attia, a medical influencer whose emails with the late sex offender Jeffrey Epstein were revealed in the latest U.S. Justice Department release of files, has resigned a post with CBS News. Attia, podcast host and author of Outlive: The Science & Art of Longevity, was one of a group of people named last month by CBS News editor-in-chief Bari Weiss as a contributor to network programming. He was the subject of a 60 Minutes profile that ran on the network last October. But shortly after the appointment, Attias name surfaced in hundreds of Epstein documents. (2/23)

Among several fridges inside the Harvard Medical School lab of renowned geneticist George Church is one devoted to housing tubes of human blood and spit destined to have their cellular contents cracked open, the DNA letters read out and posted to the wilds of the open internet. Eventually.(Molteni, 2/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF